Summary
This business is focused on developing a new class of epigenetic medicines aimed at revolutionizing the treatment of genetically driven diseases. By leveraging the natural mechanisms of gene regulation, they aim to create genomic therapeutics that provide precise control over gene expression without altering the DNA sequence itself. Their approach is based on advanced research in the field of genomic medicine, promising durable and specific treatments.
Based on content on chromamedicine.com
kronosbio.com
San Mateo, CA
Biotechnology focused on cancer and autoimmune disease therapeutics.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
3.1 years — Since Nov 2021
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
541714
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Pharmaceuticals
2. Research and Development in Biotechnology (except Nanobiotechnology)
Vendor
Source
Apple
TXT Record
Atlassian
TXT Record
DocuSign
TXT Record
Mimecast
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|